Results 121 to 130 of about 7,538 (211)

Safety and Pharmacokinetics of the Anti-Orthopoxvirus Compound ST-246 following a Single Daily Oral Dose for 14 Days in Human Volunteers [PDF]

, 2012
Jarasvech Chinsangaram, Kady M. Honeychurch, Shanthakumar Tyavanagimatt, Janet M. Leeds, Tové C. Bolken, Kevin F. Jones, Robert Jordan, Thomas Marbury, Jon Ruckle, Denis Mee-Lee, Eric A. Ross, Israel Lichtenstein, Margaret Pickens, Michael L. Corrado, Jean Μ. Clarke, Annie Frimm, Dennis E. Hruby   +16 more
openalex   +1 more source

Molecular Aspects of the Emergence of Monkeypox Virus Clades. [PDF]

Viruses
Babkin IV, Babkina IN, Tikunova NV.
europepmc   +1 more source

The orthopoxvirus type I IFN binding protein is essential for virulence and an effective target for vaccination [PDF]

, 2008
Ren-Huan Xu, Matthew E. Cohen, Yong Tang, Eric Lazear, J. Charles Whitbeck, Roselyn J. Eisenberg, Gary H. Cohen, Luis J. Sigal   +7 more
openalex   +1 more source

Six Cases of Borealpox and Evidence of a Zoonotic Source-Alaska, 2020-2023. [PDF]

Clin Infect Dis
Mooring EQ, Rogers J, Whitehill F, Werle Z, Gigante CM, Matheny A, Conley C, Westley BP, Kunkel A, Newell KG, Minhaj FS, Li Y, Morgan CN, Wilkins K, Davidson W, Nakazawa Y, McCollum AM, Olson V, Petersen BW, Castrodale LJ, Olson LE, Gunderson AM, Doty JB, McLaughlin JB.   +23 more
europepmc   +1 more source

Mpox Epidemics: A Call to Restore Humanity's Lost Herd Immunity to Orthopoxviruses. [PDF]

Viruses
Wayengera M, Kyobe-Bosa H, Muttamba W, Olu OO, Gueye AS, Ndembi N, Kamara N, Folayan MO, Kirenga B, Luo S, Li Q, Ihekweazu C.   +11 more
europepmc   +1 more source

Effects of pre-existing orthopoxvirus-specific immunity on the performance of Modified Vaccinia virus Ankara-based influenza vaccines [PDF]

, 2018
Arwen F. Altenburg, Stella E. van Trierum, Erwin de Bruin, Dennis de Meulder, Carolien E. van de Sandt, Fiona van der Klis, Ron A. M. Fouchier, Marion Koopmans, Guus F. Rimmelzwaan, Rory D. de Vries   +9 more
openalex   +1 more source

A human recombinant analogue to plasma-derived vaccinia immunoglobulin prophylactically and therapeutically protects against lethal orthopoxvirus challenge

, 2021
Scott Parker, June Ann D’Angelo, R. Mark L. Buller, Donald F. Smee, Johan Lantto, Henriette Svarre Nielsen, Allan Jensen, Mark N. Prichard, Sarah L. George   +8 more
openalex   +2 more sources

Anti-orthopoxvirus drugs inhibit lumpy skin disease virus replication by targeting viral DNA polymerase. [PDF]

PLoS Pathog
Gong Z, Dai J, Qu H, Hu Y, Sun F, Liu C, Li X, Feng C, Wang Z, Yang Z, Liu G.   +10 more
europepmc   +1 more source

Non-Human Primate Models of Orthopoxvirus Infections [PDF]

, 2014
Anne Schmitt, Kerstin Mätz‐Rensing, Franz‐Josef Kaup   +2 more
openalex   +1 more source

Protective Properties of Vaccinia Virus-Based Vaccines: Skin Scarification Promotes a Nonspecific Immune Response That Protects against Orthopoxvirus Disease [PDF]

, 2014
Amanda D. Rice, Mathew M. Adams, Scott F. Lindsey, Daniele M. Swetnam, Brandi R. Manning, Andrew Smith, Andrew M. Burrage, Greg Wallace, Amy L. MacNeill, Richard W. Moyer   +9 more
openalex   +1 more source